Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting
Authors
Ondiek, JNamukaya, Z
Mtapuri-Zinyowera, S
Balkan, S
Elbireer, A
Ushiro Lumb, I
Kiyaga, C
Goel, N
Ritchie, A
Ncube, P
Omuomu, K
Ndiege, K
Kekitiinwa, A
Mangwanya, D
Fowler, Mary G
Nadala, L
Lee, H
Issue Date
2017-06-09Submitted date
2017-06-26
Metadata
Show full item recordAbstract
Early diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings.Publisher
Lippincott Williams & WilkinsPubMed ID
28604503Language
enISSN
1944-7884ae974a485f413a2113503eed53cd6c53
10.1097/QAI.0000000000001476